Akari Therapeutics Names Wendy DiCicco Interim Finance Chief
By Ben Glickman Akari Therapeutics said Wednesday it has named Wendy DiCicco interim chief financial officer. The London-based biotechnology company said...
Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Akari Therapeutics said Wednesday it has named Wendy DiCicco interim chief financial officer. The London-based biotechnology company said...
By Ben Glickman Shares of Akari Therapeutics rose Thursday after the company said it had received a positive opinion on a drug treatment's application for...
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ:AKTX opened at $0.16 on Friday. The stock has a 50-day simple moving average of $0.18 and a two-hundred day simple […]
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 0.6 % Shares of NASDAQ:AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 12-month low of $0.14 and […]
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 1-year low of $0.14 and a 1-year high of $1.61. The stock […]